Original Source(s)
Related Content
APT may fall short in pulsatile tinnitus
Low sensitivity and specificity suggest a negative tracing should not deter further imaging evaluation.
October 9, 2026
-
3 min
Endometrial cancer drug cuts progression or death risk 41%
FDA grants Priority Review following improved survival versus chemotherapy in phase 3 trial.
by Mouj Hijazi
October 27, 2026
-
3 min
FDA approves pritelivir for refractory HSV lesions
In a phase 3 trial, complete lesion healing occurred in 63% of patients receiving pritelivir vs. 34% receiving comparator treatments.
by Teraya Smith
October 9, 2026
-
2 min
